FDA Drug Application (021729) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021729
Product Number002
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage10MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE



Back to FDA Applications sponsored by OTSUKA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.